These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23033288)

  • 41. Plasma TM2-PK levels in mycosis fungoides patients.
    Hapa A; Erkin G; Hasçelik G; Pektaş D; Arslan U
    Arch Dermatol Res; 2011 Jan; 303(1):35-40. PubMed ID: 20927531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pretreatment risk factors for overall survival in patients with gastrointestinal and non-gastrointestinal mucosa associated lymphoid tissue lymphomas.
    Virijevic M; Perunicic-Jovanovic M; Djunic I; Novkovic A; Mihaljevic B
    J BUON; 2014; 19(1):178-82. PubMed ID: 24659661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulin.
    Melchardt T; Troppan K; Weiss L; Hufnagl C; Neureiter D; Tränkenschuh W; Hopfinger G; Magnes T; Deutsch A; Neumeister P; Hackl H; Greil R; Pichler M; Egle A
    Br J Haematol; 2015 Jan; 168(2):239-45. PubMed ID: 25236324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.
    Chen Y; Neelapu S; Feng L; Bi W; Yang TH; Wang M; Fanale MA; Westin JR; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Fowler NH; McLaughlin P; Cabanillas F; Oki Y; Nastoupil LJ; Rodriguez A
    Br J Haematol; 2016 Oct; 175(2):290-299. PubMed ID: 27448187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of serum beta-2 microglobulin in patients with non-Hodgkin lymphoma.
    Wu L; Wang T; Gui W; Lin H; Xie K; Wang H; Gao T; Zhang X; Liu L; Han T; Tian Y; Hou L
    Oncology; 2014; 87(1):40-7. PubMed ID: 24969158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum IL-6, IL-8, IL-10 and beta2-microglobulin in association with International Prognostic Index in diffuse large B cell lymphoma.
    Duletić-Nacinović A; Stifter S; Marijić B; Lucin K; Valković T; Petranović D; Jonjić N
    Tumori; 2008; 94(4):511-7. PubMed ID: 18822687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta 2 microglobulin level as an indicator of prognosis in diffuse large cell lymphoma.
    Avilés A; Zepeda G; Díaz-Maqueo JC; Rodriguez L; Guzmán R; García EL; Talavera A
    Leuk Lymphoma; 1992 May; 7(1-2):135-8. PubMed ID: 1472924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beta-2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B-cell lymphoma.
    Kanemasa Y; Shimoyama T; Sasaki Y; Tamura M; Sawada T; Omuro Y; Hishima T; Maeda Y
    Hematol Oncol; 2017 Dec; 35(4):440-446. PubMed ID: 27238634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.
    Yoo C; Yoon DH; Jo JC; Yoon S; Kim S; Lee BJ; Huh J; Lee SW; Suh C
    Ann Hematol; 2014 Jun; 93(6):995-1000. PubMed ID: 24441948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase.
    Rodriguez J; Pugh WC; Romaguera JE; Luthra R; Hagemeister FB; McLaughlin P; Rodriguez MA; Swan F; Cabanillas F
    Ann Oncol; 1994 Nov; 5(9):847-9. PubMed ID: 7848887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated vascular endothelial growth factor pretreatment levels are correlated with the tumor burden in Hodgkin lymphoma and continue to be elevated in prolonged complete remission.
    Rueda A; Olmos D; Villareal V; Torres E; Pajares BI; Alba E
    Clin Lymphoma Myeloma; 2007 May; 7(6):400-5. PubMed ID: 17621405
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical relevance of elevated levels of serum soluble interleukin-2 receptor alpha (sIL-2Rα) in patients with non-Hodgkin's lymphoma.
    Jo SA; Hwang SH; Chang CL; Kim SY; Shin HJ; Chung JS; Sol MY; Lee EY
    Korean J Lab Med; 2010 Dec; 30(6):600-5. PubMed ID: 21157146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Value of serum beta 2 microglobulin as an indicator of early relapse in diffuse large cell lymphoma.
    Avilés A; Narváez BR; Díaz-Maqueo JC; Guzmán R; Talavera A; García EL
    Leuk Lymphoma; 1993 Mar; 9(4-5):377-80. PubMed ID: 7688627
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of parameters with potential prognosis impact in patients with primary gastric diffuse large B-cell lymphoma (PG-DLBCL).
    Rotaru I; Găman GD; Stănescu C; Găman AM
    Rom J Morphol Embryol; 2014; 55(1):15-21. PubMed ID: 24715160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Plasma interleukin-6 and interleukin-10 levels in different subtypes of lymphoma and their clinical significance].
    Wang X; Zhao HR; Gu X; Liu P; Bikmituofu H
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1360-4. PubMed ID: 21868324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors.
    Reiser M; Josting A; Soltani M; Staib P; Salzberger B; Diehl V; Engert A
    Leuk Lymphoma; 2002 Apr; 43(4):805-11. PubMed ID: 12153168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pretreatment levels of vascular endothelial growth factor in plasma predict a complete remission rate and time to relapse or progression in patients with diffuse large B-cell lymphoma.
    Lech-Maranda E; Bienvenu J; Broussais-Guillaumot F; Michallet AS; Warzocha K; Biliński P; Boyle P; Coiffier B; Salles G
    Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):165-74. PubMed ID: 23283519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: correlation with clinical outcome.
    Lossos IS; Natkunam Y; Levy R; Lopez CD
    Leuk Lymphoma; 2002 Dec; 43(12):2309-17. PubMed ID: 12613517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Expression of MCP-1 and CCR2 in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Clinical Significance].
    Wang M; Zhang PP; Zhu Q; Hu ZL; Bai X; Wu YP; Li JJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):112-119. PubMed ID: 38387908
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical significance of beta 2-microglobulin in serum of adult T cell leukemia.
    Sadamori N; Mine M; Hakariya S; Ichiba M; Kawachi T; Itoyama T; Nakamura H; Tomonaga M; Hayashi K
    Leukemia; 1995 Apr; 9(4):594-7. PubMed ID: 7723390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.